Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a paper Ben Ponvilawan and colleagues on X:
“Long-Term Survival by ICIs in PD-L1–Negative mNSCLC
ICI-based therapy is more effective than ChT
In squamous histology, dual ICI regimens appear to be more effective than single ICI
In non-squamous, single or doublet ICI shows similar efficacy.”
Authors: Ben Ponvilawan et al.
